PubRank

Andreas Zimmer

Author PubWeight™ 190.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell 2009 3.63
2 GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 2004 3.38
3 Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 2005 3.02
4 Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011 2.71
5 Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2009 2.54
6 Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 2005 2.52
7 Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 2002 2.24
8 Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest 2013 2.23
9 Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 2003 2.21
10 An ancient genome duplication contributed to the abundance of metabolic genes in the moss Physcomitrella patens. BMC Evol Biol 2007 2.17
11 A role for ASIC3 in the modulation of high-intensity pain stimuli. Proc Natl Acad Sci U S A 2002 2.11
12 Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 2005 2.07
13 Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A 2008 1.97
14 Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 2006 1.95
15 Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nat Methods 2005 1.93
16 Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 2010 1.82
17 Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 2007 1.70
18 A practical note on the use of cytotoxicity assays. Int J Pharm 2004 1.63
19 A tarantula peptide against pain via ASIC1a channels and opioid mechanisms. Nat Neurosci 2007 1.49
20 The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J Neurosci 2005 1.47
21 Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 2006 1.46
22 Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 2009 1.44
23 Mouse phenotyping. Methods 2010 1.43
24 Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 2011 1.41
25 Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 2010 1.39
26 Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J Neurosci 2008 1.32
27 B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts. Mol Cell Biol 2004 1.28
28 Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci 2009 1.28
29 Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. J Comp Neurol 2008 1.25
30 Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One 2009 1.25
31 A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 2003 1.17
32 Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2007 1.15
33 Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomedicine 2008 1.15
34 Cytotoxicity of nanoparticles independent from oxidative stress. J Toxicol Sci 2009 1.13
35 Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 2005 1.13
36 The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci 2002 1.12
37 The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J 2009 1.12
38 Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. Eur J Neurosci 2009 1.09
39 CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res Cardiol 2010 1.09
40 Innovations in phenotyping of mouse models in the German Mouse Clinic. Mamm Genome 2012 1.09
41 The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm Bowel Dis 2010 1.07
42 An integrated genome research network for studying the genetics of alcohol addiction. Addict Biol 2010 1.07
43 Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 2002 1.05
44 Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain. J Neurosci 2008 1.05
45 Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice. J Biol Chem 2011 1.05
46 Antinociceptive effects of novel A2B adenosine receptor antagonists. J Pharmacol Exp Ther 2003 1.05
47 The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 2007 1.04
48 Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion. Eur J Pharm Biopharm 2011 1.03
49 Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev 2010 1.02
50 N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice. Neuropsychopharmacology 2011 1.02
51 Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice. Neuropsychopharmacology 2005 1.02
52 The major central endocannabinoid directly acts at GABA(A) receptors. Proc Natl Acad Sci U S A 2011 1.02
53 Drug delivery of oligonucleotides by peptides. Eur J Pharm Biopharm 2004 1.02
54 Control of hormonal stress reactivity by the endogenous opioid system. Psychoneuroendocrinology 2008 1.02
55 Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 2005 1.01
56 Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol 2006 1.01
57 Analysis of the mouse transcriptome for genes involved in the function of the nervous system. Genome Res 2003 1.00
58 SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance. PLoS One 2013 1.00
59 Dissolution testing of hardly soluble materials by surface sensitive techniques: clotrimazole from an insoluble matrix. Pharm Res 2014 1.00
60 An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc Natl Acad Sci U S A 2011 0.99
61 Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology 2011 0.99
62 Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver Int 2011 0.98
63 Incongruent pattern of neurokinin B expression in rat and mouse brains. Cell Tissue Res 2005 0.97
64 CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc Natl Acad Sci U S A 2012 0.97
65 Modulation of alcohol and nicotine responses through the endogenous opioid system. Prog Neurobiol 2009 0.97
66 Analysis of the cellular expression pattern of beta-CGRP in alpha-CGRP-deficient mice. J Comp Neurol 2004 0.96
67 The opioid peptides enkephalin and beta-endorphin in alcohol dependence. Biol Psychiatry 2008 0.95
68 High mobility group N proteins modulate the fidelity of the cellular transcriptional profile in a tissue- and variant-specific manner. J Biol Chem 2013 0.95
69 The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis Rheum 2009 0.95
70 Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol 2012 0.94
71 CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. J Bone Miner Res 2011 0.94
72 An fMRI study on the acute effects of exercise on pain processing in trained athletes. Pain 2012 0.94
73 Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia. J Neurosci 2012 0.93
74 Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis. Am J Pathol 2010 0.93
75 Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology (Berl) 2004 0.92
76 Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice. Int J Neuropsychopharmacol 2008 0.92
77 Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS One 2012 0.92
78 Recombinant virus like particles as drug delivery system. Curr Pharm Biotechnol 2005 0.92
79 Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood 2007 0.92
80 Behavioral changes in G72/G30 transgenic mice. Eur Neuropsychopharmacol 2009 0.92
81 Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier. J Control Release 2006 0.92
82 Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6. Eur Neuropsychopharmacol 2009 0.90
83 Peroxisomes in human and mouse testis: differential expression of peroxisomal proteins in germ cells and distinct somatic cell types of the testis. Biol Reprod 2007 0.90
84 Cannabinoids and the skeleton: from marijuana to reversal of bone loss. Ann Med 2009 0.90
85 Anandamide effects on 5-HT(3) receptors in vivo. Eur J Pharmacol 2008 0.90
86 Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. J Mol Cell Cardiol 2011 0.89
87 Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 ( 416insG ) mice. Mamm Genome 2009 0.89
88 Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin. Neuropharmacology 2009 0.89
89 Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization. Eur J Pharm Biopharm 2005 0.88
90 Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution. J Control Release 2005 0.87
91 Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice. Eur J Pharm Biopharm 2013 0.87
92 Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol 2008 0.87
93 Lineage conversion of murine extraembryonic trophoblast stem cells to pluripotent stem cells. Mol Cell Biol 2011 0.87
94 Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles. Oligonucleotides 2006 0.87
95 Comparison of antisense oligonucleotide drug delivery systems. J Control Release 2004 0.86
96 THC Prevents MDMA Neurotoxicity in Mice. PLoS One 2010 0.86
97 A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology 2013 0.86
98 SMC6 is an essential gene in mice, but a hypomorphic mutant in the ATPase domain has a mild phenotype with a range of subtle abnormalities. DNA Repair (Amst) 2013 0.86
99 Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm 2014 0.86
100 Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. Int J Biochem Cell Biol 2010 0.86
101 Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation. Neuropeptides 2010 0.85
102 Dynorphins regulate fear memory: from mice to men. J Neurosci 2012 0.85
103 The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes. Am J Physiol Gastrointest Liver Physiol 2012 0.85
104 Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction. J Control Release 2005 0.85
105 A common genetic predisposition to stress sensitivity and stress-induced nicotine craving. Biol Psychiatry 2007 0.85
106 Studies in humans and mice implicate neurocan in the etiology of mania. Am J Psychiatry 2012 0.85
107 The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. Basic Res Cardiol 2014 0.85
108 Construction of a global pain systems network highlights phospholipid signaling as a regulator of heat nociception. PLoS Genet 2012 0.84
109 Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation. J Control Release 2004 0.84
110 Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. Proc Natl Acad Sci U S A 2011 0.84
111 Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol 2008 0.84
112 Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. Exp Cell Res 2013 0.84
113 Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides. Eur J Pharm Biopharm 2005 0.84
114 Cannabinoid receptor CB2 protects against balloon-induced neointima formation. Am J Physiol Heart Circ Physiol 2012 0.83
115 Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours. Psychopharmacology (Berl) 2007 0.83
116 Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci U S A 2013 0.83
117 Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect. Eur J Pharm Biopharm 2005 0.83
118 Ibuprofen-loaded calcium stearate pellets: drying-induced variations in dosage form properties. AAPS PharmSciTech 2012 0.83
119 Aggressive behaviour and physiological responses to pheromones are strongly impaired in mice deficient for the olfactory G-protein -subunit G8. J Physiol 2013 0.82
120 Impaired D-serine-mediated cotransmission mediates cognitive dysfunction in epilepsy. J Neurosci 2013 0.82
121 Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation. J Lipid Res 2013 0.82
122 Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. J Control Release 2008 0.82
123 The transcription factor Smad-interacting protein 1 controls pain sensitivity via modulation of DRG neuron excitability. Pain 2011 0.82
124 Long-term ethanol effects on acute stress responses: modulation by dynorphin. Addict Biol 2012 0.82
125 Visceral, inflammatory and neuropathic pain in glycine receptor alpha 3-deficient mice. Neuroreport 2005 0.82
126 Role of Pituitary Adenylate-Cyclase Activating Polypeptide and Tac1 gene derived tachykinins in sensory, motor and vascular functions under normal and neuropathic conditions. Peptides 2013 0.81
127 Involvement of the primate specific gene G72 in schizophrenia: From genetic studies to pathomechanisms. Neurosci Biobehav Rev 2012 0.81
128 CRISPR/Cas-induced double-strand breaks boost the frequency of gene replacements for humanizing the mouse Cnr2 gene. Biochem Biophys Res Commun 2013 0.81
129 CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain. Neurochem Int 2008 0.81
130 Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int J Pharm 2007 0.81
131 Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int J Pharm 2011 0.81
132 Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. J Psychiatr Res 2012 0.81
133 Differential scanning fluorescence approach using a fluorescent molecular rotor to detect thermostability of proteins in surfactant-containing formulations. Int J Pharm 2012 0.81
134 VPAC receptor mediated tumor cell targeting by protamine based nanoparticles. J Drug Target 2010 0.81
135 Increased systemic efficacy of aphidicolin encapsulated in liposomes. Oncol Rep 2005 0.80
136 Myocardial hypertrophy is associated with inflammation and activation of endocannabinoid system in patients with aortic valve stenosis. Life Sci 2013 0.80
137 The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts. J Biol Chem 2012 0.80
138 Quantitative trait loci contributing to physiological and behavioural ethanol responses after acute and chronic treatment. Int J Neuropsychopharmacol 2009 0.80
139 Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1⁻/⁻ mice. Neurobiol Aging 2010 0.80
140 The buccal mucosa as a route for TiO2 nanoparticle uptake. Nanotoxicology 2014 0.80
141 Crystallographic textures and morphologies of solution cast Ibuprofen composite films at solid surfaces. Mol Pharm 2014 0.80
142 In vitro release of propofol and binding capacity with regard to plasma constituents. Eur J Pharm Biopharm 2008 0.80
143 The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample. Hum Genet 2009 0.80
144 Environmental modulation of anxiety-related neuronal activity and behaviors. Behav Brain Res 2007 0.80
145 MiR-34a deficiency accelerates medulloblastoma formation in vivo. Int J Cancer 2014 0.79
146 Role of tachykinin 1 and 4 gene-derived neuropeptides and the neurokinin 1 receptor in adjuvant-induced chronic arthritis of the mouse. PLoS One 2013 0.79
147 Modulation of the CRH system by substance P/NKA in an animal model of depression. Behav Brain Res 2010 0.79
148 P2X(3) receptor expression at early stage of mouse embryogenesis. Mech Dev 2002 0.79
149 Nanomolar ambient ATP decelerates P2X3 receptor kinetics. Neuropharmacology 2008 0.79
150 Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques. Int J Nanomedicine 2011 0.79
151 Transcription factor TFAP2C regulates major programs required for murine fetal germ cell maintenance and haploinsufficiency predisposes to teratomas in male mice. PLoS One 2013 0.79
152 Deficits in sensory-specific devaluation task performance following genetic deletions of cannabinoid (CB1) receptor. Learn Mem 2009 0.78
153 Functional characterization of P2X3 receptors fused with fluorescent proteins. Mol Membr Biol 2005 0.78
154 Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm Res 2015 0.78
155 In-vitro permeability of neutral polystyrene particles via buccal mucosa. Small 2012 0.78
156 Central sensitization needs sigma receptors. Pain 2009 0.78
157 Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors. Immunobiology 2010 0.78
158 Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors. Neurochem Int 2012 0.78
159 Physicochemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzyme. J Liposome Res 2009 0.78
160 Exposure of mice to long-light: a new animal model to study depression. Eur Neuropsychopharmacol 2010 0.77
161 Identification of the mitochondrial MSRB2 as a binding partner of LG72. Cell Mol Neurobiol 2014 0.77
162 Formation of a physical stable delivery system by simply autoclaving nanostructured lipid carriers (NLC). Int J Pharm 2012 0.77
163 Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 2012 0.77
164 Preproenkephalin knockout mice show no depression-related phenotype. Neuropsychopharmacology 2007 0.77
165 Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasia. PLoS One 2011 0.77
166 Standardized, systemic phenotypic analysis of Slc12a1I299F mutant mice. J Biomed Sci 2014 0.77
167 A genetical genomics approach reveals new candidates and confirms known candidate genes for drip loss in a porcine resource population. Mamm Genome 2013 0.77
168 Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation. J Immunol 2013 0.77
169 Evaluating the effects of buffer conditions and extremolytes on thermostability of granulocyte colony-stimulating factor using high-throughput screening combined with design of experiments. Int J Pharm 2012 0.77
170 Clinical potential of VIP by modified pharmaco-kinetics and delivery mechanisms. Endocr Metab Immune Disord Drug Targets 2012 0.77
171 Germ cells of male mice express genes for peroxisomal metabolic pathways implicated in the regulation of spermatogenesis and the protection against oxidative stress. Histochem Cell Biol 2011 0.77
172 Development of lipophilic calcium stearate pellets using ibuprofen as model drug. Eur J Pharm Biopharm 2010 0.77
173 The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model. Eur J Pharm Biopharm 2013 0.77
174 Analysis of quantitative trait loci in mice suggests a role of Enoph1 in stress reactivity. J Neurochem 2013 0.76
175 Engineering cell-permeant FLP recombinase for tightly controlled inducible and reversible overexpression in embryonic stem cells. Stem Cells 2010 0.76
176 Pegylated human interferon alpha 2a does not induce depression-associated changes in mice. Psychiatry Res 2010 0.76
177 Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior. PLoS One 2013 0.76
178 Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant. Inflamm Res 2014 0.76
179 Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations. Biochem Biophys Res Commun 2013 0.76
180 Correction: Expression Analysis of CB2-GFP BAC Transgenic Mice. PLoS One 2015 0.75
181 Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging. Curr Med Chem 2015 0.75
182 Factors mediating alcohol craving and relapse: stress, compulsivity, and genetics. Alcohol Clin Exp Res 2005 0.75
183 CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol. Ann N Y Acad Sci 2015 0.75
184 Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory. Front Aging Neurosci 2012 0.75
185 Reformulation of a codeine phosphate liquid controlled-release product. Drug Dev Ind Pharm 2010 0.75
186 Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization. Drug Dev Ind Pharm 2011 0.75
187 Rapid screening method for antisense oligonucleotides against human growth factor receptor p185(erbB-2). Oligonucleotides 2004 0.75
188 Monolithic precolumns as efficient tools for guiding the design of nanoparticulate drug-delivery formulations. Anal Chem 2012 0.75
189 Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol 2013 0.75
190 [Methods to increase the encapsulation efficiency for liposomal drugs]. Acta Pharm Hung 2008 0.75
191 A collaboration investigating endocannabinoid signalling in brain and bone. J Basic Clin Physiol Pharmacol 2016 0.75
192 Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy. Eur J Pharm Biopharm 2004 0.75
193 Whole-Exome-Sequencing Reveals Small Deletions in CASP14 in Patients with Autosomal Recessive Inherited Ichthyosis. Acta Derm Venereol 2017 0.75
194 Target-sequence Capture and High Throughput Sequencing Identify a De novo CARD14 Mutation in an Infant with Erythrodermic Pityriasis Rubra Pilaris. Acta Derm Venereol 2016 0.75
195 Altered host response to murine gammaherpesvirus 68 infection in mice lacking the tachykinin 1 gene and the receptor for substance P. Neuropeptides 2010 0.75
196 New protamine quantification method in microtiter plates using o-phthaldialdehyde/N-acetyl-L-cysteine reagent. Int J Pharm 2004 0.75
197 Microstructure of calcium stearate matrix pellets: a function of the drying process. J Pharm Sci 2013 0.75
198 Effect of protamine on the solubility and deamidation of human growth hormone. Int J Pharm 2012 0.75
199 Behavioural changes induced by a conditional disruption of bone formation. J Basic Clin Physiol Pharmacol 2016 0.75